Pages that link to "Q38320344"
Jump to navigation
Jump to search
The following pages link to Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods (Q38320344):
Displaying 50 items.
- Modern Technologies for Creating Synthetic Antibodies for Clinical application (Q30467308) (← links)
- Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides (Q33645793) (← links)
- Effect of small-molecule-binding affinity on tumor uptake in vivo: a systematic study using a pretargeted bispecific antibody (Q33649168) (← links)
- Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts (Q33780787) (← links)
- Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants. (Q34029619) (← links)
- Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex (Q34033063) (← links)
- PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach (Q34165944) (← links)
- Systemic radiotherapy can cure lymphoma: a paradigm for other malignancies? (Q34335207) (← links)
- Quantitating antibody uptake in vivo: conditional dependence on antigen expression levels (Q34400470) (← links)
- Arming antibodies: prospects and challenges for immunoconjugates (Q34449555) (← links)
- Novel radiolabeled antibody conjugates (Q34631801) (← links)
- Evaluation of glycodendron and synthetically modified dextran clearing agents for multistep targeting of radioisotopes for molecular imaging and radioimmunotherapy. (Q34731015) (← links)
- CD20-targeted tetrameric interferon-alpha, a novel and potent immunocytokine for the therapy of B-cell lymphomas (Q34999743) (← links)
- Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging (Q35162177) (← links)
- High-yielding aqueous 18F-labeling of peptides via Al18F chelation (Q35228332) (← links)
- Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis (Q35509695) (← links)
- Dextran-conjugated vascular endothelial growth factor receptor antibody for in vivo melanoma xenografted mouse imaging (Q35831897) (← links)
- A general chemical synthesis platform for crosslinking multivalent single chain variable fragments (Q35835544) (← links)
- Radiolabelled monoclonal antibodies in the treatment of metastatic cancer (Q35840380) (← links)
- Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric Nanomedicines (Q35861726) (← links)
- Cancer Imaging and Therapy with Bispecific Antibody Pretargeting (Q36082355) (← links)
- Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody. (Q36212978) (← links)
- Non-invasive longitudinal imaging of tumor progression using an (111)indium labeled CXCR4 peptide antagonist (Q36338306) (← links)
- Tailoring antibodies for radionuclide delivery (Q36349687) (← links)
- Feasibility of Affibody Molecule-Based PNA-Mediated Radionuclide Pretargeting of Malignant Tumors (Q36372344) (← links)
- Advances in radioimmunotherapy in the age of molecular engineering and pretargeting (Q36391426) (← links)
- Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis (Q36543499) (← links)
- Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody (Q36979699) (← links)
- Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct (Q37146338) (← links)
- An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector (Q37154201) (← links)
- A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations (Q37201878) (← links)
- A semiempirical model of tumor pretargeting (Q37288717) (← links)
- Pretargeted PET Imaging Using a Site-Specifically Labeled Immunoconjugate (Q37403530) (← links)
- Click Chemistry and Radiochemistry: The First 10 Years (Q37540109) (← links)
- From bench to bedside: the growing use of translational research in cancer medicine. (Q37698244) (← links)
- The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86. (Q37869905) (← links)
- Continuing pursuit for ideal systemic anticancer radiotherapeutics (Q37946750) (← links)
- Pretargeting: taking an alternate route for localizing radionuclides (Q37991245) (← links)
- The inverse electron demand Diels-Alder click reaction in radiochemistry (Q38172061) (← links)
- New insights into the pretargeting approach to image and treat tumours. (Q38976879) (← links)
- Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide (Q39486574) (← links)
- Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition (Q39809931) (← links)
- In vitro evaluation of avidin antibody pretargeting using 211At-labeled and biotinylated poly-L-lysine as effector molecule (Q39904017) (← links)
- Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques. (Q42972140) (← links)
- Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody (Q43175903) (← links)
- Engineering therapeutic monoclonal antibodies (Q47820029) (← links)
- CD38 pretargeted RIT of B-cell tumors. (Q50037145) (← links)
- Synthesis, characterization, and biological evaluation of new biotinylated (99m) Tc/Re-tricarbonyl complexes. (Q52887163) (← links)
- In vivo demonstration of an active tumor pretargeting approach with peptide nucleic acid bioconjugates as complementary system. (Q55093431) (← links)
- Sensitivity of pretargeted immunoPET using 68Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18FDG PET-CT. (Q55286801) (← links)